Piramal Pharma Ltd’s Post

"Unveiling 5 years of dedication, growth, and countless memories at Piramal Pharma Ltd. 🌟 This certificate symbolizes not just years of service, but the invaluable lessons learned, friendships made, and challenges conquered along the way. Each milestone reminds me of the incredible journey I've been privileged to embark on. Here's to embracing the past with gratitude and stepping into the future with unwavering optimism! 🚀💼 #PiramalPharma #JourneyOfGratitude"

Complexity of simplification lies in the fact that idea can come from even an industry fresher and hence it's important to not ignore any. The two ends of any idea i.e. intent to implementation need a string of contribution support from every member. Great leaders help in building the string with their constant motivation. Kudos to you for building a good team and congratulations to you and your whole team and bringing idea to implementation

Anish Ranpise & Siraj Singh talk about their experience working with SUN PHARMA. They talk about the kind of Autonomy & Ownership they give employees, that is something to be applauded for. Freedom to make decisions & the trust they put in employees leads to the growth of professionals and ultimately to the company. If you like the short, watch the full conversation with the Sun Pharma team here- https://lnkd.in/g8Ujy-bD #sunpharma #mba #iima #iimb

“Is India's Largest Pharma Deal Brewing?”💊🤝 In the 7th issue of "Ikshana", Vyuham - The Consulting Club, IIM Visakhapatnam presents before you Torrent Pharmaceuticals Ltd exploring a monumental acquisition of Cipla, valued💵 at around INR 60,000 crore ($7.2 billion). Financing requires a blend of debt and equity, including investments from private equity firms and foreign banks. The merger aims to create a pharmaceutical powerhouse 🏥 with diverse product portfolios and global reach, but it faces challenges such as EPS dilution, regulatory hurdles, and complex integration. To gain a deeper understanding of the topic, swipe left!! 👈🏻 #Cipla #Torrentpharma #Acquisition #Consulting #Vyuham #IIM

ONE TEAM! 'Sanofi HUBS' #gbs #gcc across #hyderabad #budapest #bogota #kualalumpur We are one team, We Never Settle. Our joint ambition is to elevate Sanofi’s commitment to #innovation and #excellence through the delivery of best-in-class enterprise services enabling Sanofi to move at pace in its ambition to transform the practice of medicine #sanofi #sanofistories #careerswithpurpose #careers #DiscoverExtraordinary We’re one team working in relay around the world for one purpose—every single day. As global healthcare company, we want to build a healthier world by discovering, developing, and delivering medicines and vaccines for millions of people around the world. That’s why we chase the miracles of science to improve people’s lives. https://lnkd.in/gjxuAX85

NEVER SETTLE! Yul Moldauer lives by the motto “embrace the grind” This is the second of six back stories from Team Sanofi and Sanofians, all of them a tribute to the people who ignited their potential and taught them to never settle. Learn More: https://lnkd.in/guG9Psit #paris2024 #olympics2024 We at Sanofi HUBS #gbs #gcc across #hyderabad #budapest #bogota #kualalumpur Never Settle, our joint ambition is to elevate Sanofi’s commitment to #innovation and #excellence through the delivery of best-in-class enterprise services enabling Sanofi to move at pace in its ambition to transform the practice of medicine. #sanofi #sanofistories #careerswithpurpose #careers We are expanding teams across our HUBS - Sanofi Global Business #operations #procurement #hr #people #medical #commercial #dataanalytics #finance #transition #manufacturing #supplychain #researchdevelopment #digital #informationtechnology #sharedservices Know the opportunities at https://lnkd.in/gir6Ee6F Pursue Progress. Discover Extraordinary. Madeleine RoachAnna MassotMrinal DuggalBalazs SOOKI-TOTHPablo MurtaSivakumar SivagurunathanCatrin BusattiRohit JoshiAudrey CleggMelvin MahIstvan MatitsJuliana Ayazo VillaShivani AthawleDaniel Perkins

#Inspiration abounds at Biocon Biologics ! Recently, I facilitated our CEO & MD connect session with a diverse group of new joiners from India and Asia, as a part of "New Employees Orientation"! The #stories shared by our newly joined fellow colleagues across several countries, were truly moving - a father's dream for his daughter to join the company that makes his diabetes medication, a mother's battle with cancer inspiring her daughter to work towards serving patients through our medicines, rejoining employees stories of connecting to our vision. and many more such stories. Employees stories are always powerful, when it reflects organisation's #purpose ! Shreehas Tambe - our CEO & MD's own journey is an inspirational story and a testament to the power of purpose, perseverance, excellence and dreaming big. His key messages in this session resonated deeply with us: -Sense of Purpose: Remember "why we do -what we do" and be driven by purpose. - Work In Progress - Continuous Excellence is key and strive for the next best version - Dare to Dream: Both in organizational and Individual growth. Feeling #inspired alongside my new colleagues. I wish everyone a fantastic career journey ahead of them at Biocon Biologics! Shreehas Tambe Naveen Narayanan Smrity Arora Dhruv Taneja Sravanti Chekragari Chandrakala R Schonali Rebello #BioconBiologics #CEOConnect #PurposeDriven #ExcellenceMatters #DreamBig #EmployeeStories #LifeAtBBL

🔍 Exciting Insights into Cipla: Comparative Company Analysis 🚀 Thrilled to share a comprehensive analysis of Cipla, diving deep into key performance metrics, market trends, and strategic positioning. 📊 🔸 Financial Health: Cipla's robust financials showcase resilience and growth, making it a standout player in the pharmaceutical sector. 🔸 Market Share: Unpacking market dynamics, we explore how Cipla has successfully expanded its market presence, outperforming competitors. 🔸 Innovation Hub: Delving into Cipla's R&D initiatives, we highlight the company's commitment to innovation, paving the way for future growth. 🔸 Global Footprint: An exploration of Cipla's global reach, showcasing its ability to navigate international markets and adapt to diverse regulatory landscapes. 🔸 Sustainability Initiatives: Cipla's strides in sustainability underscore its commitment to responsible business practices and environmental stewardship. Join the conversation! Let's discuss the fascinating journey of Cipla and its impact on the pharmaceutical landscape. 💬 #Cipla #CompanyAnalysis

Stock of the Month: Biocon Ltd. Busiess: Biocon is among the Top 15 bio-manufacturing companies globally. Expected to be big multibegger in next 3 to 5 years. Fundamentals: In 2021-22, the company has made strategic investments & acquired the global biosimilars business of long-term partner Viatris for USD 3.3 billion & also made other strategic investment. These investment put pressure on bottom line & EPS. Company went into profit de-growth & Dec'22 quarter was closed in Red. Company's share price has given negative 3% CAGR growth in last three year However in FY'24, company has shown remarkable recovery in both Top line & Bottom line & EPS likely to be more than doubled in FY24. Technical chart: Company had made all time high in Dec'20 @ 487 & there after made more than 60% correction upto 190 in Mar'23. Presently price has recovered & now trading ~300/- Both Fundamentals & Technical Supporting Biocon to rise. Disclaimer: Above post is for education purpose only, please consult your Invesment Advisor before committing in any Investment.

Today, the Indian pharma ecosystem is booming, but are organizations able to keep up? As part of our #LeadersExchangeSeries, Global Talent Exchange recently hosted a spirited discussion between 8 experts to tackle the critical shortage of skilled talent in the industry. The need of the hour is new ideas, diverse perspectives, and groundbreaking approaches - and that is exactly what this session consisted of. The vision is coming to life and the road to success is clearer. Watch the complete video - Out on #YouTube NOW! https://lnkd.in/gbiVcSjJ Anjali Rao Novartis India Jayal Shah Zydus Group Sanket Salvi Servier Ekta Chhoda Bayer Ambesh Battula - AB MANKIND PHARMA LTD Anju Chaudhary Boehringer Ingelheim Swagatika Sahoo Glenmark Pharmaceuticals Avinash Bichali Yadunandan Monani Sharnitha suraj Sameera A. Khanna #IndianPharma #PharmaResearch #ResearchandDevelopment #TalentAcquisition #GlobalTalent #Recruitment #GlobalHiring #TalentMobility